Using cells from cadavers, doctors have been experimentally transplanting pancreatic islets into
humans for decades, but as many as 60 percent of the transplanted islets die immediately because they are cut off from their blood supply and are killed by an immune response due to direct injection into the
bloodstream, and those that survive the transplant usually die
within several months.